发明名称 |
Method of treating hyperphotaemia using lanthanum hydroxycarbonate |
摘要 |
This disclosure relates to the treatment of subjects at risk for chronic kidney disease (CKD), having stage one to five CKD, having hyperphosphataemia, susceptible to or suffering from soft tissue calcification associated with CKD, or susceptible to or suffering from hyperparathyroidism, by orally administering a pharmaceutical composition containing a therapeutically effective amount of lanthanum hydroxycarbonate. |
申请公布号 |
ZA200701707(B) |
申请公布日期 |
2008.10.29 |
申请号 |
ZA20070001707 |
申请日期 |
2007.02.27 |
申请人 |
SHIRE PHARMACEUTICALS, INC. |
发明人 |
FERDINANDO, JOSEPHINE, CHRISTINE;GILMOUR DAVID |
分类号 |
A61K |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|